Nevro Corp (NYSE:NVRO)
$ 5.08 -0.26 (-4.87%) Market Cap: 189.40 Mil Enterprise Value: 157.99 Mil PE Ratio: 0 PB Ratio: 0.69 GF Score: 44/100

Nevro Corp at Jefferies Healthcare Conference Transcript

Jun 08, 2023 / 02:30PM GMT
Release Date Price: $23.6 (+2.08%)
Matt Taylor
Jefferies - Analyst

Welcome to our next session here. So I'm Matt Taylor, the US medical supplies and devices analyst here at Jefferies. And I'm pleased to be joined here by the management team from Nevro, and we're meant to have a 25-minute or so fireside chat. So I'll be asking some questions of the team here.

Just want to introduce everybody first. The CEO and President, Kevin Thornal, who recently joined the company. So it would be great to hear from Kevin. Good to meet you in person, Kevin. And in the middle of the table, there is Rob MacLeod, the CFO; and also Julie Dewey at the end there, who's at both the Chief Communications and IR. And so thanks, everybody, for joining us.

So I wanted to start high level and just talk a little bit about maybe some of the history to give people orientation on the story. Because Nevro has been a real disruptor in the SCS market through history with high frequency. And they're continuing to innovate with data and with some of your new offerings like the HFX platform. So maybe you could expound on that, talk about the philosophy of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot